Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 4, Issue 9 (2015)

Molecular docking studies of indole derivatives containing cyanide group as hepatitis C Ns5b polymerase inhibitor

Author(s):
Thayaillany Rajandran, Radha Prabhu, M Prabhu
Abstract:
Hepatitis C is a liver disease caused by the Hepatitis C virus (HCV) and the infection has affected approximately 180 million people around the world. Nonstructural protein 5B (NS5B) polymerase is a viral protein found in HCV and it plays a major role in the replication of the virus. Over the decade, it has been found that inhibition of the enzyme prevents the replication of the virus and thus treats the disease. In this study, molecular docking was performed on a series of indole derivatives by Autodock 4.2 into active sites of NS5B polymerase enzyme.
Pages: 43-48  |  1364 Views  19 Downloads


The Pharma Innovation Journal
How to cite this article:
Thayaillany Rajandran, Radha Prabhu, M Prabhu. Molecular docking studies of indole derivatives containing cyanide group as hepatitis C Ns5b polymerase inhibitor. Pharma Innovation 2015;4(9):43-48.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal